Paper23934740
Insertion sequence IS18 mediates overexpression of blaOXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolate.
Zander E and 2 others. J Antimicrob Chemother, 2014. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Insertion sequence IS18 mediates overexpression of blaOXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolate. Papers, record 23934740. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23934740
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Insertion sequence IS18 mediates overexpression of blaOXA-257 in a carbapenem-resistant Acinetobacter bereziniae isolate.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acinetobacter | Major topic |
| Anti-Bacterial Agents | Major topic |
| Carbapenems | Major topic |
| DNA Transposable Elements | Major topic |
| Gene Expression Regulation, Bacterial | Major topic |
| beta-Lactam Resistance | Major topic |
| beta-Lactamases | Major topic |
| DNA, Bacterial | |
| Humans | |
| Molecular Sequence Data | |
| Mutagenesis, Insertional | |
| Sequence Analysis, DNA |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40506592 | Integrons: the hidden architects of bacterial adaptation, evolution, and the challenges of antimicrobial resistance. | Antonie Van Leeuwenhoek | 2025 | https://conductscience.org/library/papers/40506592 | PubMed |
| 39336804 | Co-Occurrence of Two Plasmids Encoding Transferable blaNDM-1 and tet(Y) Genes in Carbapenem-Resistant Acinetobacter bereziniae. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39336804 | PubMed |
| 39150777 | Adaptive evolution of carbapenem-resistant hypervirulent Klebsiella pneumoniae in the urinary tract of a single patient. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39150777 | PubMed |
| 36699260 | First identification of multidrug-resistant Acinetobacter bereziniae isolates harboring bla NDM-1 from hospitals in South China. | Heliyon | 2023 | https://conductscience.org/library/papers/36699260 | PubMed |
| 36316792 | Mobile genetic elements in Acinetobacter antibiotic-resistance acquisition and dissemination. | Ann N Y Acad Sci | 2022 | https://conductscience.org/library/papers/36316792 | PubMed |
| 31743332 | Characterization of the diverse plasmid pool harbored by the blaNDM-1-containing Acinetobacter bereziniae HPC229 clinical strain. | PLoS One | 2019 | https://conductscience.org/library/papers/31743332 | PubMed |
| 26966220 | Draft Genome Sequence of Acinetobacter bereziniae HPC229, a Carbapenem-Resistant Clinical Strain from Argentina Harboring blaNDM-1. | Genome Announc | 2016 | https://conductscience.org/library/papers/26966220 | PubMed |
| 24696435 | OXA β-lactamases. | Clin Microbiol Rev | 2014 | https://conductscience.org/library/papers/24696435 | PubMed |
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| GENBANK | KC567681 |
Source GENBANK
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23934740
GET https://conductscience.org/api/papers/v1/23934740/authors